Scientists test common Antibiotic's power against stubborn lung infection
NCT ID NCT04287049
Summary
This small, completed study aimed to measure how effectively the antibiotic azithromycin kills the bacteria that cause Mycobacterium Avium Complex (MAC) lung disease in the first two weeks of treatment. It involved 10 adults with MAC lung disease who were about to start standard treatment. Researchers tracked changes in bacteria levels in participants' sputum to understand the drug's initial impact.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM AVIUM COMPLEX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.